Skip to main content
Oncotarget logoLink to Oncotarget
. 2024 Aug 26;15:590. doi: 10.18632/oncotarget.28645

Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1

Ling Xiao 1,2,3, Hui Zhou 4, Xiang-Ping Li 1,2, Juan Chen 1,2, Chao Fang 1,2, Chen-Xue Mao 1,2, Jia-Jia Cui 1,2, Wei Zhang 1,2, Hong-Hao Zhou 1,2, Ji-Ye Yin 1,2,, Zhao-Qian Liu 1,2,
PMCID: PMC11348940  PMID: 39189975

This article has been retracted: There is internal duplication in Figures 2C and 4C. The same image was found to be duplicated in four other papers: Figures 4 and 7 from [1], Figure 3C, 3D [2], Figure 4C from [3]; and Figures 3B and 6B from [4].

Figure 4A duplicates Figure 5A from [5] and Figure 3G from [6]. The authors acknowledged the misuse of the images. The Scientific Integrity Committee of Xyangui Hospital investigated the paper and agreed with the retraction. As a result, the Editorial decision was made to retract this paper. All authors agreed with the decision.

Original article: Oncotarget. 2016; 7:40038–40046. 40038-40046. https://doi.org/10.18632/oncotarget.9480

REFERENCES

  • 1. Aili A, Chen Y, Zhang H. MicroRNA-10b suppresses the migration and invasion of chondrosarcoma cells by targeting brain-derived neurotrophic factor. Mol Med Rep. 2016; 13:441–46. 10.3892/mmr.2015.4506. . Retraction in: Mol Med Rep. 2021; 24:569. . [DOI] [PubMed] [Google Scholar]
  • 2. Zhang C, Long F, Wan J, Hu Y, He H. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2. Oncol Rep. 2016; 35:3275–84. 10.3892/or.2016.4700. . Retraction in: Oncol Rep. 2021; 46:155. . [DOI] [PubMed] [Google Scholar]
  • 3. Lai C, Chen Z, Li R. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1. Mol Med Rep. 2015; 12:1473–78. 10.3892/mmr.2015.3545. . Retraction in: Mol Med Rep. 2021; 24:546. . [DOI] [PubMed] [Google Scholar]
  • 4. Shi Y, Huang J, Zhou J, Liu Y, Fu X, Li Y, Yin G, Wen J. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1. Oncol Rep. 2015; 34:399–406. 10.3892/or.2015.3986. . Retraction in: Oncol Rep. 2021; 46:147. . [DOI] [PubMed] [Google Scholar]
  • 5. Su F, Chen Y, Zhu S, Li F, Zhao S, Wu L, Chen X, Su J. RAB22A overexpression promotes the tumor growth of melanoma. Oncotarget. 2016; 7:71744–53. 10.18632/oncotarget.12329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Yang P, Bu P, Li C. miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican. Exp Ther Med. 2017; 14:3555–62. 10.3892/etm.2017.4998. . Retraction in: Exp Ther Med. 2023; 27:58. . [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES